正在加载公司
Just reported
Q2 FY2027 results
From Doximity's results release of 2026年11月5日; its quarterly report has since been filed.
Revenue
Actual
US$174.5M
+3.6% y/y
+11% q/qGuided
US$170.5M
midpoint
Above guide+2.4%EPS, GAAP
Actual
US$0.18
-42% y/y
+38% q/qGuided
—
No guide given
EPS, adjusted: US$0.36
Operating income, GAAP
Actual
US$43.9M
-31% y/y
+31% q/qGuided
—
No guide given
Company outlook
Q3 FY2027
- RevenueUS$195M – US$196M+5.6% y/y First given
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
Keep exploring
The themes Doximity is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Highest-graded in Health Information Services
Graded A or B and worth $2B or more: A first, then the largest.
VEEVVeeva Systems Inc.US$49.4BA+
BTSGBrightSpring Health Services, Inc.US$14.4BA
HNGEHinge Health, Inc.US$9.9BA+
HQYHealthequity, Inc.US$8.5BA+
WAYWaystar Holding Corp.US$5.5BB+
Grade rose recently in Healthcare
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
DHRDanaher Corporation2026年10月21日CBGraded C, now B
MCKMckesson Corporation2026年11月4日BAGraded B, now A
CVSCVS Health Corp2026年11月4日BAGraded B, now A
EWEdwards Lifesciences Corporation2026年11月4日BAGraded B, now A
BIIBBiogen Inc.2026年10月28日BAGraded B, now A
基于 Doximity, Inc. 自己向美国证券交易委员会（SEC）提交的申报文件。数字如实呈报，每股历史已重述到今天的股数口径。 这是对一门生意的描述——不是投资建议，也不是买卖任何证券的推荐。
